Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study.
about
Why Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?Molecular diagnostic testing for primary biliary cholangitis.Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis.Finding the cure for primary biliary cholangitis - Still waiting.Geoepidemiology and changing mortality in primary biliary cholangitis.Old and new treatments for primary biliary cholangitis.Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.Treatment of PBC-A step forward.Primary biliary cholangitis: a comprehensive overview.Chronic Autoimmune Epithelitis in Sjögren's Syndrome and Primary Biliary Cholangitis: A Comprehensive Review.Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.Investigational drugs in phase II clinical trials for primary biliary cholangitis.Update on pharmacotherapies for cholestatic liver disease.Toward solving the etiological mystery of primary biliary cholangitis.Cholestatic liver diseases: new targets, new therapies
P2860
Q33840969-97ED7B51-00CA-49DC-BF84-6809F6C249E3Q36086498-FE0FA605-AA14-46D0-BCC0-463B6B53762CQ36708065-A43A0C3D-A3F8-4F56-9447-2DBE16FA9F62Q37642274-73A01BB2-04B6-4CEF-AA74-D8B9AA3CD48BQ38858980-210A5FBE-17D8-4754-8C08-DEEACC653B6EQ39213467-9C15E46C-2EE3-4C4C-81DF-C383A1A481DCQ39216355-423B7E77-FE53-40DE-80E3-16641BDB3A15Q40044046-AB109530-BD86-4418-9CF5-4136FB1150A8Q44129027-C5C024CF-E560-4B82-A202-B9989D7DE31CQ46078221-32C29075-C36F-43BC-BEC9-BE71C85B120AQ47146987-A5A8581A-26F5-4F56-BCA8-103C567B8A8FQ47827554-D01D904E-FA8F-4B72-AC2B-1C2BF77B2F95Q53098304-EAF3B676-5313-48ED-9280-32B5E8D04AE2Q55333522-D4695611-5FA0-4E92-923E-5ED77D4C88E6Q55387422-73BFFB93-8046-4776-96EE-46D9A5C1F1CCQ57111104-240D16AB-ADA9-4070-9238-7AB17F8970E1
P2860
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ustekinumab for patients with ...... cid: A proof-of-concept study.
@en
type
label
Ustekinumab for patients with ...... cid: A proof-of-concept study.
@en
prefLabel
Ustekinumab for patients with ...... cid: A proof-of-concept study.
@en
P2093
P2860
P356
P1433
P1476
Ustekinumab for patients with ...... cid: A proof-of-concept study.
@en
P2093
Bidisha Dasgupta
Cynthia Levy
David Jones
Gideon M Hirschfield
Hanns-Ulrich Marschall
Ivo P Nnane
Jewel Johanns
Katherine Li
Keith Lindor
P2860
P304
P356
10.1002/HEP.28359
P407
P577
2015-11-24T00:00:00Z